Replimune Group Inc buy BMO Capital Markets
Start price
22.11.24
/
50%
€15.40
Target price
22.11.25
€17.31
Performance (%)
-75.84%
Price
07:30
?
Summary
This prediction is currently active. Massive losses of -75.84% have been the result for the BUY prediction by BMO_Capital_Markets. This prediction currently runs until 22.11.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Replimune Group Inc | -4.000% | -4.000% |
| iShares Core DAX® | -0.446% | 2.321% |
| iShares Nasdaq 100 | -0.671% | 3.178% |
| iShares Nikkei 225® | -1.289% | 4.197% |
| iShares S&P 500 | -0.662% | 2.125% |
Comments by BMO_Capital_Markets for this prediction
In the thread Replimune Group Inc diskutieren
Replimune Group, Inc. (NASDAQ: REPL) had its price target raised by analysts at BMO Capital Markets from $14.00 to $18.00. They now have an "outperform" rating on the stock.
Ratings data for REPL provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Replimune Group Inc
Replimune Group Inc
Start price
Target price
Perf. (%)
€12.90
22.01.25
22.01.25
€25.92
22.01.26
22.01.26
-71.78%
07:30
07:30
